Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility".
Glenmark Pharmaceuticals Limited Press Release Nov 27 2025
Filed with NSE · · 2 pages · English
Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q1 2026 Earnings Call · Replay · Aug 3Read the transcript of Glenmark Pharmaceuticals (NSE:GLENMARK) Q1 2026 Earnings CallRelease
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Nov 25 2025
- Q2FY 2025-26
- Press Release Nov 18 2025
- Press Release Nov 14 2025
- Press Release Nov 10 2025
Later from Glenmark Pharmaceuticals
- Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe
- Glenmark Pharmaceuticals Limited Press Release Dec 11 2025
- Press Release Dec 16 2025
- Glenmark Pharmaceuticals Limited Press Release Dec 23 2025
- Press Release Jan 30 2026
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals